Effects of two combined oral contraceptives containing ethinyl estradiol 20 μg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism

This publication has 26 references indexed in Scilit:

• A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles
  Contraception, 2004
• An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables
  Contraception, 2002
• A 12-month clinical investigation with a 24-day regimen containing 15 μg ethinylestradiol plus 60 μg gestodene with respect to hemostasis and cycle control
  Contraception, 2001
• Clinical implications. Biological coagulation findings in third-generation oral contraceptives
  Human Reproduction Update, 1999
• Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms
  Obstetrics & Gynecology, 1997
• Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism
  Journal of Clinical Endocrinology & Metabolism, 1995
• NIH Consensus conference. Triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease
  Published by American Medical Association (AMA) ,1993
• A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel
  Contraception, 1992
• The Evolution of Oral Contraceptives: Maximizing Efficacy, Minimizing Risks
  Acta Obstetricia et Gynecologica Scandinavica, 1990
• The analysis of vaginal bleeding patterns induced by fertility regulating methods
  Contraception, 1986